Special articleNutritional support at the end of life
References (12)
- et al.
Definition and classification of cancer cachexia: An international consensus
Lancet Oncol
(2011) - et al.
Restrictive diets in the elderly: Never say never again?
Clin Nutr
(2010) - et al.
Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects
Ann Oncol
(2011) - WHO. WHO definition of palliative care. Available at: http://www.who.int/cancer/palliative/definition/en/. Accessed May...
- et al.
The concept of cachexia-related suffering (CRS) in palliative cancer care
Position of the American Dietetic Association: Ethical and legal issues in nutrition, hydration, and feeding
J Am Diet Assoc
(2008)
Cited by (34)
Caregivers’ Death-Preparedness States Impact Caregiving Outcomes and Patients’ End-of-Life Care
2022, Journal of Pain and Symptom ManagementPotentially Inappropriate Treatments at the End of Life in Nursing Home Residents: Findings From the PACE Cross-Sectional Study in Six European Countries
2021, Journal of Pain and Symptom ManagementCitation Excerpt :In long-term use, polypharmacy, comorbidities, and age-related alterations in drug metabolism can result in side-effects that cause functional and cognitive impairment in older adults.16–18 Artificial nutrition and hydration,19–21 resuscitation22,23 and artificial ventilation24–26 can have deleterious effects on quality of life when used in the last week and can complicate the dying process while blood transfusion, chemo/radiotherapy, dialysis, or surgery can be futile and burdensome with low survival rates and resulting in poor quality of life.10–12,14 Earlier studies on potentially inappropriate treatments are limited to describing prevalence in one country or comparison between countries in specific settings such as home care27 or during the last month of life.28
Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study
2021, Clinical NutritionCitation Excerpt :An unmet need for nutritional support, e.g., PNH, may be a cause of eating-related distress in patients and family members, and integrated palliative, supportive, and nutritional care is vital to alleviate eating-related distress [17]. However, the prevalence of the implementation of artificial nutrition and hydration, including enteral tube feeding and PNH, in palliative care settings and the benefits or risks of PNH in cancer patients with survival of weeks to months remain largely unknown [1–11]. Therefore, we conducted a multicenter prospective cohort study in palliative care units across Japan to investigate the current implementation of artificial nutrition and hydration.
Experiences, Personal Attitudes, and Professional Stances of Swiss Health Care Professionals Toward Voluntary Stopping of Eating and Drinking to Hasten Death: A Cross-Sectional Study
2021, Journal of Pain and Symptom ManagementCitation Excerpt :Eating together is described as an important part of the day that is conducted in familiar communities and is described as valuable.2 In this respect, there is a direct effect on the social environment and health care professionals when an individual refuses to eat and drink.3–5 For various reasons, patients forego eating and drinking.
Beliefs and Perceptions About Parenteral Nutrition and Hydration by Family Members of Patients With Advanced Cancer Admitted to Palliative Care Units: A Nationwide Survey of Bereaved Family Members in Japan
2020, Journal of Pain and Symptom ManagementCitation Excerpt :In terminally ill patients with cancer, decisions to withhold or withdraw potentially life-prolonging treatment, such as parenteral nutrition and hydration, are frequently made in palliative care settings.1–8
Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study
2017, European Journal of CancerCitation Excerpt :Enteral nutrition is recommended when the patient's digestive tract is functional, while parenteral nutrition remains a second-line option because of increasing toxicity [17]. The use of artificial nutrition is, however, not recommended in patients with an expected life-expectancy shorter than 3 months because of unclear clinical benefit [18,19]. Our study aimed to evaluate the prevalence of aggressive cancer treatments over the course of the last 3 months of life of hospitalised patients with metastatic oesophageal or gastric cancer, and to identify the factors associated with the use of chemotherapy and artificial nutrition near the end of life.